Abstract
To overcome major side-effects, that is, cardiotoxicity of doxorubicin (DOX), pH-responsive dextrin nanogels (DNGs) were developed for using as a smart drug carrier. DOX-loaded DNGs were fabricated by emulsion cross-linking technique using glyoxal as a cross-linking agent to form acid-sensitive, acetal bonds. The objective of this study was to investigate the cytotoxicity of DOX-loaded DNGs on the human osteosarcoma 143B cell line. The cytotoxicity assay results showed that DOX-loaded DNGs retained high cell inhibition efficiency in 143B cells in a concentration- and treatment time-dependent manner. The cytotoxicity decreased with increasing ratio of glyoxal to dextrin. Observation of 143B cells by light microscopy showed the morphological changes after treatment with DOX-loaded DNGs. These results suggested that DOX-loaded DNGs with pH-sensitive properties is promising for use as a drug delivery system for cancer therapy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
